Alberts Cellular Therapy /ID# 228896

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Follicular lymphoma

Running trials

• Active, not recruiting

  Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

  NCT05409066· Phase 3· Genmab· Source